Ian T. Clark, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 529,600 shares at $28.83 ($15.7M) on 2025-12-19, disclosed to the SEC on 2025-12-23.
Open-market sale of $15.7M OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.83 | 29,904 | $862K | 5.5% |
| 2 | $28.83 | 29,904 | $862K | 5.5% |
| 3 | $29.71 | 193,056 | $5.7M | 36.4% |
| 4 | $29.71 | 193,056 | $5.7M | 36.4% |
| 5 | $30.48 | 41,840 | $1.3M | 8.1% |
| 6 | $30.48 | 41,840 |
| $1.3M |
| 8.1% |
| Total | $29.73 avg | 529,600 | $15.7M | 100% |
| Filing → |
| GH | SELL | 2025-12-08 | $5.8M | — | Filing → |
| GH | SELL | 2025-06-20 | $646K | — | Filing → |
| GH | SELL | 2024-11-14 | $458K | — | Filing → |